Group 1 - The core focus of Baoxin Technology (002514) in the past week has been on the ongoing regulatory investigation due to suspected violations of information disclosure, which has led to a negative impact on investor sentiment [1] - As of February 8, 2026, eight A-share companies have been investigated this year, with Baoxin Technology being one of them since January 30, 2026 [1] - The investigation has prompted shareholder compensation claims, particularly related to non-operational fund occupation, indicating potential compliance risks for the company [1] Group 2 - Baoxin Technology's stock price exhibited significant volatility over the past week, with a notable increase of 5.92% to 5.55 yuan on February 9, 2026, followed by a decline of 4.20% to 5.25 yuan on February 12, and a further drop of 0.95% to 5.20 yuan on February 13 [2] - The stock's trading range over the week reached 27.48%, and its total market capitalization decreased to 3.744 billion yuan [2] - Technical indicators suggest that the stock price is near the lower Bollinger Band (support level at 4.79 yuan), with a weak MACD indicator and a decline in trading volume after a spike on February 9-10, reflecting market sentiment heavily influenced by the regulatory events [2]

Core Viewpoint - Tian Sheng New Materials has received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws, leading to a formal investigation [1][5]. Group 1: Company Announcement - On February 6, 2026, Tian Sheng New Materials announced that it received a notice of investigation (No. 0102026008) from the CSRC regarding suspected violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][5]. - As of the announcement date, the company has not received the final investigation conclusion from the CSRC, and the outcome will be determined by the CSRC's findings [1][5]. Group 2: Stock Performance and Market Impact - Following the announcement of the investigation, on February 12, 2026, Tian Sheng New Materials' stock closed at 6.7 yuan per share, with a market capitalization of 2.184 billion yuan [2][5]. Group 3: Investor Compensation - Investors who purchased Tian Sheng New Materials shares before February 6, 2026, and sold or held them after February 7, 2026, may be eligible for compensation [2][5]. - The preliminary compensation range includes shares bought between the company's listing and February 6, 2026, with claims to be finalized based on court rulings [3][6]. Group 4: Required Documentation for Claims - Investors seeking compensation must provide original trading statements stamped by their brokerage, showing all transactions of Tian Sheng New Materials shares [3][6]. - Additional required documents include copies of the investor's ID, and a securities account inquiry statement from the brokerage [4][7].

Core Viewpoint - Wuxi Commercial Building Dae Oriental Co., Ltd. received a warning letter from Jiangsu Regulatory Bureau due to inaccurate financial data disclosure, which may lead to potential claims from affected investors [1][2][3]. Group 1: Company Background - Dae Oriental announced on February 12, 2026, that it received a warning letter for insufficient accounting treatment regarding investments in affiliated partnerships, leading to inaccurate financial data from 2022 to 2024 [1][3]. Group 2: Investor Compensation - Affected investors who purchased shares between April 20, 2023, and January 29, 2026, and held them until after January 30, 2026, may voluntarily register for compensation through the "Sina Investor Rights Protection Platform" [2][4][6]. - The specific compensation range will be determined by the court [6].

Core Viewpoint - The company, Kairuide, reported a significant decline in revenue and an increase in net loss for the year 2025, primarily due to a challenging domestic coal market and strategic business adjustments [1][3]. Financial Performance - The company achieved a revenue of 465 million CNY, a year-on-year decrease of 25.89% [1][2]. - The net profit attributable to shareholders was -22.18 million CNY, representing an 11-fold increase in losses compared to the previous year [1]. - The gross margin for coal trading decreased by 2.18% during the reporting period [1][2]. Business Operations - Kairuide operates mainly in the coal trading sector, utilizing both self-operated and agency models, with a focus on self-operated business [1]. - The company has adjusted its business strategy to control the scale of operations in response to market pressures [1]. Cash Flow and Legal Issues - The net cash flow from operating activities increased by 158.88% to 252,200 CNY, despite the net loss, due to timely collection of sales receivables [3]. - The company is facing multiple shareholder lawsuits related to past management's illegal activities, which may pose additional risks [3]. Regulatory Actions - Kairuide received an administrative penalty of 8 million CNY for failing to disclose certain external guarantees and significant litigation matters [3]. Shareholder Activity - The second-largest shareholder, Nonggu Group, plans to reduce its stake by up to 3% through market transactions starting December 21, 2025 [4]. - As of the report, Kairuide's stock price decreased by 2.65% to 7.70 CNY per share, with a total market capitalization of approximately 2.831 billion CNY [4][6].

Core Viewpoint - The company, Qianyin High-Tech, is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to potential claims from affected investors [1][4]. Financial Reporting Issues - Qianyin High-Tech announced corrections to previous accounting errors and adjustments to its financial statements for 2023 and 2024, with KPMG providing a qualified opinion on the 2024 financial report due to issues related to accounts receivable from three distilleries and another company [1][3]. - The company identified that the three distilleries faced operational difficulties due to market conditions, and one associated company had liquidity issues since 2023, prompting a reassessment of the impairment losses on receivables [2][7]. - The company plans to recognize a 20% impairment loss on the receivables from the distilleries as of the end of 2023, with a potential 100% impairment loss in 2024 if the receivables remain uncollectible [2][7]. Legal and Compensation Actions - Investors who purchased Qianyin High-Tech shares between March 23, 2024, and April 30, 2025, and sold or held them after April 30, 2025, are eligible to prepare for claims against the company [4][8]. - The law firm representing investors has also initiated claims for another company, Renzi Hang, which has faced similar legal issues, indicating a broader trend of investor compensation actions in the market [4][8].

Core Viewpoint - The announcement from Zhejiang Sunflower Health Technology Co., Ltd. (stock code: 300111) regarding a formal investigation by the China Securities Regulatory Commission (CSRC) due to misleading statements and violations of information disclosure has triggered a significant compensation claim process affecting 130,000 shareholders [1][2]. Group 1: Company Background and Events - On September 22, 2025, Sunflower announced a restructuring plan to acquire 100% of Xipu Materials and 40% of Beid Pharmaceutical, aiming to enter the semiconductor materials sector, which led to a surge in stock price and an increase in shareholder numbers from 60,000 to 130,000 within three months [1]. - A deep investigation by Zhitong Finance on December 25, 2025, revealed that Xipu Materials' core production capacity was fabricated, with the factories not operational and lacking necessary permits, contradicting the restructuring proposal [2]. - Following the investigation, the Shenzhen Stock Exchange issued a notice requiring Sunflower to verify the authenticity of its production capacity and related transactions, but the company failed to provide satisfactory responses, leading to the CSRC's formal investigation and the termination of the restructuring plan on January 14, 2026 [2]. Group 2: Market Reaction and Financial Impact - The stock price of Sunflower plummeted following the investigation, with a 10% drop on December 26, 2025, and an additional 10% decline after the announcement of the investigation, culminating in a 20% limit down on January 15, 2026, resulting in significant losses for investors [2]. - As of February 2, 2026, the stock price was reported at 4.39 yuan, a substantial decrease from the peak value during the restructuring hype, indicating severe financial repercussions for investors [2]. Group 3: Compensation Process - Investors who purchased Sunflower shares between September 22, 2025, and December 25, 2025, and held them through the latter date are eligible to file for compensation without upfront legal fees, as per the provisions of the Securities Law of the People's Republic of China [3]. - A call to action for affected shareholders to gather trading records and other necessary documentation to pursue claims through legal channels has been emphasized, with guidance available from legal professionals [3].

Core Viewpoint - The planned industrial transformation of Sunflower (300111) has been abruptly halted due to a notice of investigation from the China Securities Regulatory Commission (CSRC), and the 40 million yuan acquisition deposit remains unpaid [1][3]. Group 1: Investigation and Termination of Restructuring - Sunflower received a notice of investigation from the Zhejiang CSRC and announced the termination of its restructuring plan due to non-compliance with the conditions for issuing shares to purchase assets [3]. - The company intended to acquire 100% of the shares of Zhangzhou Xipu Materials Technology Co., Ltd. to enter the high-end semiconductor materials sector, but this plan has now failed [3]. Group 2: Financial Implications and Investor Rights - Sunflower paid a 40 million yuan acquisition deposit to Shanghai Xipu in September 2025, and the company has requested a refund following the termination of the transaction [3]. - The stock price of Sunflower dropped significantly, with a 10% decline on the announcement day, followed by a 20% limit down the next day and a further drop of 17.94% on the third day, resulting in substantial losses for investors [8]. - Affected investors are encouraged to pursue legal action for compensation, with a specific claim period set for shares purchased between September 22, 2025, and December 25, 2025 [6][8].

Group 1 - The company *ST Changyao has been found to have falsified financial reports from 2021 to 2023, leading to a penalty of 10 million yuan and a warning from the China Securities Regulatory Commission (CSRC) [1][4] - The company will face mandatory delisting procedures starting January 26, 2026, due to significant violations [1][4] - The total inflated revenue reported by the company over three years amounts to over 700 million yuan, with specific instances of profit inflation identified [1][4] Group 2 - A total of 14 individuals associated with the company have been fined a combined 31 million yuan, with the former general manager receiving a lifetime ban from the securities market [2][4] - Despite recent stock price increases, the company is still on track for delisting, and affected investors are encouraged to participate in compensation claims [3][5] - Investors who purchased shares within specified time frames are eligible for compensation claims, regardless of the company's delisting status [5]

Group 1 - The core issue involves investor compensation claims against Renzi Hang (任子行) due to false statements leading to financial losses [1][4] - The law firm representing the investors has filed a new case with the Shenzhen Intermediate People's Court, following a previous first-instance victory for investors [1][4] - Renzi Hang was found to have inflated its operating income by amounts of 36,951,333.48 yuan, 48,435,351.70 yuan, and 26,929,607.08 yuan from 2020 to mid-2022, which represented 4.21%, 6.97%, and 10.81% of the reported figures respectively [1][4] Group 2 - Investors who purchased Renzi Hang shares between April 28, 2021, and August 10, 2024, and sold or held them after August 10, 2024, are eligible to file compensation claims [2][5] - The law firm is also handling compensation claims for investors of Dingxin Communications (鼎信通讯), which has recently won a final judgment in a similar case [2][5] - Dingxin Communications failed to timely disclose significant changes in external conditions affecting its operations, particularly regarding a procurement freeze by the State Grid [5][6] Group 3 - The company did not disclose the disposal of shares by its controlling shareholder and actual controller in a timely manner, which is another basis for potential investor claims [6] - Investors who bought Dingxin Communications shares between March 1, 2024, and March 30, 2024, and sold or held them after March 30, 2024, can also initiate compensation claims [6]

Core Viewpoint - Hongxiang Co., Ltd. has been penalized for financial fraud and fraudulent issuance, leading to significant legal actions and potential compensation for affected investors [1][2][4]. Group 1: Financial Penalties and Legal Actions - In April 2024, Hongxiang Co., Ltd. was fined 25.13 million yuan by the Xiamen Securities Regulatory Bureau due to financial misconduct and fraudulent issuance, with the actual controller Yang Cheng receiving a lifetime market ban [1][4]. - The company has been found to have committed financial fraud for six consecutive years, resulting in a total fine of 65.56 million yuan from the regulatory authority [2][4]. - The auditing firm Rongcheng Accounting Firm and three signing accountants have also been penalized for negligence and are included as defendants in the compensation claims [1][3]. Group 2: Investor Compensation and Legal Proceedings - A lawsuit has been filed by the Shanghai Huzhi Law Firm, and affected investors can still register to join the compensation claims [1][3]. - The actual controller of Hongxiang Co., Ltd. has made an irrevocable commitment to bear a certain amount of civil compensation for the company, providing some assurance for investors seeking compensation [3]. - Investors who purchased the company's stock between November 20, 2017, and April 28, 2023, and sold or still hold shares at a loss after April 29, 2023, are eligible to join the compensation efforts, with a reminder that the statute of limitations for the case will expire on April 28 [2][4].